Healthcare - Biotechnology - NASDAQ - US
$ 0.5655
-9.14 %
$ 21.6 M
Market Cap
-0.32
P/E
BALANCE SHEET
160 M
ASSETS
47 M
LIABILITIES
113 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Bolt Biotherapeutics, Inc.
| Current Assets | 106 M |
| Cash & Short-Term Investments | 102 M |
| Receivables | 0 |
| Other Current Assets | 3.52 M |
| Non-Current Assets | 54.1 M |
| Long-Term Investments | 26.4 M |
| PP&E | 24.1 M |
| Other Non-Current Assets | 3.59 M |
| Current Liabilities | 20.5 M |
| Accounts Payable | 2.99 M |
| Short-Term Debt | 5.56 M |
| Other Current Liabilities | 11.9 M |
| Non-Current Liabilities | 26.6 M |
| Long-Term Debt | 17.4 M |
| Other Non-Current Liabilities | 9.15 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 10.8 | 9.2 | 27.4 | 5.5 | 34.8 | 13.6 |
| Short Term Investments | 91.4 | 159.6 | 158.8 | 17.3 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | (0.8) | (0.2) | 12 K | (0.3) | 0 |
| Other Current Assets | 3.5 | 3.9 | 2.9 | 2.5 | 1.1 | 0.5 |
| Total Current Assets | 105.7 | 172.7 | 189.2 | 25.4 | 35.9 | 14.1 |
| PP&E | 24.1 | 28.5 | 30.6 | 16.4 | 11.5 | 1.4 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 26.4 | 23.9 | 85.3 | 1.6 | 0.6 | 0 |
| Other Long Term Assets | 3.6 | 2.6 | 2.6 | 3.2 | 0.4 | 0.4 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 159.8 | 227.8 | 307.7 | 46.5 | 48.4 | 16.0 |
| LIABILITIES | ||||||
| Accounts Payable | 3.0 | 3.6 | 3.6 | 1.6 | 2.1 | 0.9 |
| Short Term Debt | 5.6 | 4.8 | 5.0 | 3.0 | 3.1 | 40 K |
| Other Current Liabilities | 9.7 | 12.7 | 9.9 | 5.2 | 2.9 | 1.8 |
| Total Current Liabilities | 20.5 | 23.1 | 21.3 | 11.3 | 8.7 | 2.8 |
| Long Term Debt | 17.4 | 20.2 | 21.9 | 9.4 | (70.4) | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 77.5 | 0 |
| Other Liabilities | 43 K | 42 K | 0.2 | 130.8 | (77.4) | 29.2 |
| Total Liabilities | 47.0 | 56.3 | 57.6 | 151.5 | 94.3 | 31.9 |
| EQUITY | ||||||
| Common Stock | 1 K | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (364.3) | (295.1) | (207.0) | (108.4) | (47.7) | (17.2) |
| Other Accumulative Comprehensive Income/Loss | 37 K | (0.9) | (0.3) | 0 | 0 | 0 |
| Total Equity | 112.7 | 171.5 | 250.1 | (104.9) | (45.8) | (15.9) |
| Total Liabilities and Equity | 159.8 | 227.8 | 307.7 | 46.5 | 48.4 | 16.0 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 37.8 | 37.4 | 37.4 | 36.2 | 35.1 | 9.4 |